The first COVID-19 vaccine approved for use in the United States is not available yet and it’s unclear when the first doses will be ready for administration. The Food and Drug Administration (FDA) on Aug. 23 approved a vaccine from Pfizer and its German partner, BioNTech. But at the same time, drug regulators extended (pdf) emergency use authorization (EUA) for existing doses of the vaccine. The FDA and the Centers for Disease Control and Prevention (CDC) declined to answer or did not respond to questions about when the approved vaccine, dubbed Comirnaty, would be available. Pfizer did not answer directly when asked and BioNTech did not return an inquiry. But health officials from states across America confirmed to The Epoch Times that they do not have any Comirnaty doses, and that none are expected soon. “Comirnaty-labeled doses are not yet in circulation in the U.S. yet,” a spokesman for the Arizona Department …